Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia

Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia

Author Noto, Cristiano Autor UNIFESP Google Scholar
Gadelha, Ary Autor UNIFESP Google Scholar
Belangero, Sintia I. Autor UNIFESP Google Scholar
Spindola, Leticia M. Autor UNIFESP Google Scholar
Rocha, Natalia Pessoa Google Scholar
Miranda, Aline Silva de Google Scholar
Teixeira, Antonio Lucio Google Scholar
Cardoso Smith, Marilia Arruda Autor UNIFESP Google Scholar
Mari, Jair de Jesus Autor UNIFESP Google Scholar
Bressan, Rodrigo Affonseca Autor UNIFESP Google Scholar
Brietzke, Elisa Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Universidade Federal de Minas Gerais (UFMG)
Abstract Background: Schizophrenia (SZ) has been associated with an imbalance in the inflammatory cytokine TNF-alpha. the objectives of this study were to compare TNF-alpha and its soluble receptors' serum levels in individuals with SZ with the levels found in a group of healthy volunteers and to investigate the possible association between these biomarkers and the dimensions and severity of symptoms, clinical outcomes and response to treatment in patients with SZ.Methods: Fifty-four chronically medicated SZ outpatients and 118 healthy controls were included in the study. TNF-alpha levels were measured by Cytometric Bead Assay (CBA), and serum levels of soluble tumor necrosis factor receptor 1 (sTNFR1) and soluble tumor necrosis factor receptor 2 (sTNFR2) were measured by ELISA.Results: sTNFR1 and sTNFR2 were significantly elevated in patients with SZ as compared to the healthy control group. in the group of individuals with SZ, the levels of both types of soluble TNF receptors showed a negative correlation with global functioning. sTNFR1 levels were higher in the treatment-resistant patients as compared to the non-treatment-resistant patients and the controls. sTNFR1 levels were also heightened in patients with SZ and concomitant depression.Conclusion: Our findings reinforce that SZ is associated with an inflammatory profile and suggest that sTNFR1 is a marker of a treatment-resistance and severe clinical course in SZ. (C) 2013 Elsevier B.V. All rights reserved.
Keywords Schizophrenia
Immune system
TNF-alpha receptors
Language English
Sponsor Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
Date 2013-04-01
Published in Journal of Psychiatric Research. Oxford: Pergamon-Elsevier B.V., v. 47, n. 4, p. 467-471, 2013.
ISSN 0022-3956 (Sherpa/Romeo, impact factor)
Publisher Elsevier B.V.
Extent 467-471
Access rights Closed access
Type Article
Web of Science ID WOS:000317027700006

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account